Here’s what you need to know:
1. The bill, titled the “Donald Payne Sr. Colorectal Cancer Detection Act” (H.R.6275), would extend Medicare coverage to all FDA-approved colorectal cancer screening blood-based tests.
2. The legislation is cosponsored by U.S. Representative Charlie Dent (R-Pa.) and U.S. Representative John Delaney (D-Md.).
3. This past April, the FDA approved the first blood-based screening test, a noninvasive option that detects DNA markers in a patient’s blood sample.
4. The bill is named after Mr. Payne’s late father, who passed away in 2012 from colorectal cancer.
“Colorectal cancer is one of the most preventable forms of cancer, yet it remains the second leading cause of cancer death in the United States, mainly because one in three Americans do not stay up-to-date with their screenings,” Mr. Payne said. “We need new and innovative tools to reach these patients.”
More articles on gastroenterology and endoscopy:
Patients over 75 years old may not benefit from colonoscopy: 4 study insights
FDA clears Pure-Vu System for intra-procedural colon cleaning: 3 notes
US Sen. Susan Collins honored for CRC screening initiatives: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.